Drugs / Heart-Protecting Musk Pill
Heart-Protecting Musk Pill
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05095922 | Mar 2023 → May 2024 | diabetic peripheral angiopathy, type 2 diabetes mellitus | Affiliated Hospital of Nantong University | Completed | No outcome recorded |
| Phase 4 | NCT01897805 | Jul 2011 → Jun 2015 | coronary artery disorder | Shanghai Hutchison Pharmaceuticals Limited | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Heart-protecting Musk Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01897805 ↗ |
| Known as | HMP | “Heart-Protecting Musk Pill (HMP) is a commonly used drug in clinical treatment” NCT05095922 ↗ |
| Known as | MUSKARDIA | “Shexiang Baoxin Pill (MUSKARDIA) reduces major adverse cardiovascular events in women with stable coronary artery disease: A subgroup analysis of a phase IV randomized clinical trial.” PMID 36386372 ↗ Oct 2022 |
| Known as | Shexiang Baoxin Pill | “Shexiang Baoxin Pill (MUSKARDIA) reduces major adverse cardiovascular events in women with stable coronary artery disease: A subgroup analysis of a phase IV randomized clinical trial.” PMID 36386372 ↗ Oct 2022 |
| Modality | Traditional medicine (herbal / TCM) | “To examine effects of of Heart-protecting Musk Pill, a traditional Chinese medicine, on clinical outcomes in patients with chronic stable coronary artery disease” NCT01897805 ↗ |
| Route | Oral | “2 Heart-protecting Musk Pills each time, three times a day by mouth for 24 months” NCT01897805 ↗ |